|
Breast cancer mortality reduction
|
|
Relative risk reduction
|
|
Absolute risk reduction
|
|
Survival time from diagnosis
|
|
Number needed to screen
|
|
Carcinoma in situ, as positive
|
|
Less mastectomies/more tumourectomies
|
|
Total mortality reduction
|
|
Other
|
|
Harms
|
|
Overdiagnosis and overtreatment
|
|
Recall rate:
|
|
1. Per screen
|
|
2. Cumulative
|
|
More mastectomies/more tumourectomies
|
|
Increased biopsy rate
|
|
Risks associated with additional radiotherapy
|
|
Psychological effects related to false positives
|
|
Carcinoma in situ, as negative
|
|
Pain at mammography
|
|
Other
|
